Compounds > sr141716
Page last updated: 2024-08-26

sr141716 and Bowel Diseases, Inflammatory

sr141716 has been researched along with Bowel Diseases, Inflammatory in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alhouayek, M; Cani, PD; Delzenne, NM; Lambert, DM; Muccioli, GG1
Ewan, S1
Moyer, MP; Robertson, DA; Ward, SG; Wright, KL1
Bisogno, T; Capasso, F; Capasso, R; Di Marzo, V; Esposito, G; Fezza, F; Iuvone, T; Izzo, AA; Mascolo, N; Pinto, L1

Other Studies

4 other study(ies) available for sr141716 and Bowel Diseases, Inflammatory

ArticleYear
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:8

    Topics: Animals; Arachidonic Acids; Benzodioxoles; Colitis; Disease Models, Animal; Endocannabinoids; Endotoxemia; Enzyme Inhibitors; Glycerides; Humans; Indoles; Inflammation; Inflammation Mediators; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Trinitrobenzenesulfonic Acid

2011
Weeding out new drugs.
    Drug discovery today, 2005, Oct-15, Volume: 10, Issue:20

    Topics: Analgesics; Anti-Obesity Agents; Cannabinoids; Cannabis; Clinical Trials as Topic; Humans; Hydrophobic and Hydrophilic Interactions; Inflammatory Bowel Diseases; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Solubility

2005
Long term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer.
    International journal of cancer, 2008, Apr-15, Volume: 122, Issue:8

    Topics: Adenoma; Anti-Obesity Agents; Apoptosis; Carcinoma; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dronabinol; Drug Inverse Agonism; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant

2008
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation.
    British journal of pharmacology, 2001, Volume: 134, Issue:3

    Topics: Analgesics; Animals; Cannabinoid Receptor Modulators; Cannabinoids; Cannabinol; Croton Oil; Cyclohexanols; Dermatologic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Motility; Inflammatory Bowel Diseases; Injections, Intraperitoneal; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

2001